Antimicrobial prescription behavior in 16 German intensive care units: room for improvement in pneumonia therapy by S Schneider et al.
ORAL PRESENTATION Open Access
Antimicrobial prescription behavior in 16 German
intensive care units: room for improvement in
pneumonia therapy
S Schneider1*, J Zweigner2, F Schwab1, M Behnke1, E Meyer3, P Gastmeier1
From 3rd International Conference on Prevention and Infection Control (ICPIC 2015)
Geneva, Switzerland. 16-19 June 2015
Introduction
Antimicrobial surveillance in German hospitals is mainly
based on consumption monitoring. Sparse data exist on
prescription culture.
Objectives
To investigate the performance of antimicrobial pre-
scription behavior in order to identify starting points for
interventions.
Methods
16 intensive care units (ICUs) non-university hospitals
covering Germany were included. Randomly selected
medical records from patients diagnosed with pneumonia
in 2012 were retrospectively analyzed. Bacteriological sam-
pling and antimicrobial therapy (AMT) were reviewed
with regard to clinically relevant aspects. Immunosup-
pressed, pregnant and underage patients were excluded.
Results
383 medical records were analyzed (179 community
acquired and 204 hospital acquired pneumonia cases).
40.5% of empiric therapy regimens were appropriate
according to national guidelines. Regimens with too
broad spectrum or not recommended substances were
used in 11.7%. 47.8% had formally too narrow spectra.
Duration of therapy could only be evaluated in 40.7% of
cases since the other patients were dimissed or died
before recommended end of therapy. Within the evalu-
able group 31.4% of therapies were too long. Dosing was
adequate in 86.6% of cases. Bacteriological sampling was
performed as recommended in 23.1% of cases and
incompletely in 51.2%. Performance frequencies were
49.4% for blood cultures, 41.8% for tracheal aspirate and
15.4% for bronchoalveolar lavage. Legionella antigen was
tested in only 7.6%. De-escalation strategies could be
evaluated in 76.0% of cases, since 24.0% were dismissed
before day 4. In 90% of evaluable cases no de-escalation
was performed. In 6.9% de-escalation was microbiologi-
cally guided, in 3.1% clinically guided. Documentation of
the indication for AMT was not performed in 25.5%. In
61.9% the indication was placed unsystematically in the
medical record. Documentation at a predefined place
was only found in 12.6%.
Conclusion
Large room for improvement in AMT was detected
regarding duration of therapy, performance of bacteriolo-
gical sampling, de-escalation concepts and documentation.
The high percentage of formally too narrow empiric AMT
regimens should be interpreted carefully. Further analysis




1Hygiene Institute, Charité, Berlin, Germany. 2Microbiology, Immunology,
Hygiene, University Hospital, Cologne, Germany. 3Department of Hygiene,
Städtisches Klinikum, Munich, Germany.
Published: 16 June 2015
doi:10.1186/2047-2994-4-S1-O2
Cite this article as: Schneider et al.: Antimicrobial prescription behavior
in 16 German intensive care units: room for improvement in
pneumonia therapy. Antimicrobial Resistance and Infection Control 2015
4(Suppl 1):O2.
1Hygiene Institute, Charité, Berlin, Germany
Full list of author information is available at the end of the article
Schneider et al. Antimicrobial Resistance and Infection Control 2015, 4(Suppl 1):O2
http://www.aricjournal.com/content/4/S1/O2
© 2015 Schneider et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
